13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-14, with 29 holding rows worth $753,991,000.
- Accession
- 0001144204-13-045526
- Filer
- CIK 1346824
- Filed
- 2013-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2013
A holdings report, 29 entries on the cover page, a total value of $753,991,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $753,991,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 6,529,810 | $118,516,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 5,000,000 | $90,750,000 | thousands by filing date | call |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 7,455,202 | $60,984,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 5,659,285 | $42,275,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 5,368,094 | $41,925,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 10,908,379 | $37,743,000 | thousands by filing date | |
| NEWLINK GENETICS CORP | 651511107 | COM | 1,840,294 | $36,291,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 17,170,801 | $35,200,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 11,262,608 | $34,126,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 2,433,319 | $29,102,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 1,994,876 | $26,632,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 4,716,296 | $24,454,000 | thousands by filing date | |
| XOMA CORP DEL | 98419J107 | COM | 6,698,558 | $24,316,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 3,000,000 | $23,430,000 | thousands by filing date | call |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 902,858 | $19,863,000 | thousands by filing date | |
| RECEPTOS, INC. | 756207106 | COMMON STOCK | 975,000 | $19,393,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 2,000,000 | $16,360,000 | thousands by filing date | call |
| OMEROS CORP | 682143102 | COM | 2,953,004 | $14,883,000 | thousands by filing date | |
| ONCOGENEX PHARMACEUTICALS IN | 68230A106 | COM | 863,332 | $8,461,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 436,145 | $7,724,000 | thousands by filing date | |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 1,000,000 | $7,470,000 | thousands by filing date | call |
| Enzo Biochem Inc | 294100102 | Common Stock | 3,348,029 | $6,964,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 6,000,000 | $6,600,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 497,807 | $6,427,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 3,114,755 | $6,230,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 151,000 | $4,248,000 | thousands by filing date | |
| SENOMYX INC | 81724Q107 | COM | 975,610 | $2,127,000 | thousands by filing date | |
| TRANZYME INC | 89413J102 | COM | 2,700,000 | $1,269,000 | thousands by filing date | |
| SAVIENT PHARMACEUTICALS INC | 80517QAA8 | CNV | 1,000,000 | $228,000 | thousands by filing date | principal |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-13-045526 | this filing | 2013-08-14 | acceptance time not in the bulk data set |